UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 305

Sortiert nach

Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000

Leukemia, 2010-02, Vol.24 (2), p.265-284

2010

Volltextzugriff (PDF)

IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol

Haematologica (Roma), 2013-03, Vol.98 (3), p.428-432

2013

Volltextzugriff (PDF)

Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008

Leukemia, 2010-03, Vol.24 (3), p.521-535

2010

Volltextzugriff (PDF)

Analysis of minimal residual disease by Ig TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data

Leukemia, 2007-04, Vol.21 (4), p.604-611

2007

Volltextzugriff (PDF)

Bloodstream infection in paediatric cancer centres—leukaemia and relapsed malignancies are independent risk factors

European journal of pediatrics, 2015-05, Vol.174 (5), p.675-686

2015

Volltextzugriff (PDF)

Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting

Leukemia, 2007-04, Vol.21 (4), p.706-713

2007

Volltextzugriff (PDF)

The Fc-engineered CD19 antibody MOR208 (XmAb5574) induces natural killer cell-mediated lysis of acute lymphoblastic leukemia cells from pediatric and adult patients

Leukemia, 2013-07, Vol.27 (7), p.1595-1598

2013

Volltextzugriff (PDF)

Dental status does not predict infection during stem cell transplantation: a single-center survey

Bone marrow transplantation (Basingstoke), 2017-07, Vol.52 (7), p.1041-1043

2017

Volltextzugriff (PDF)

Therapy of steroid-refractory acute GVHD with CD52 antibody alemtuzumab is effective

Bone marrow transplantation (Basingstoke), 2011-01, Vol.46 (1), p.143-147

2011

Volltextzugriff (PDF)

Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol

Leukemia, 2009-06, Vol.23 (6), p.1073-1079

2009

Volltextzugriff (PDF)

Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement

Leukemia, 2007-04, Vol.21 (4), p.633-641

2007

Volltextzugriff (PDF)

Very early early relapses of acute lymphoblastic leukemia show unexpected changes of clonal markers and high heterogeneity in response to initial and relapse treatment

Leukemia, 2011-08, Vol.25 (8), p.1305-1313

2011

Volltextzugriff (PDF)

Allogeneic hematopoietic SCT in children with ALL: current concepts of ongoing prospective SCT trials

Bone marrow transplantation (Basingstoke), 2008-06, Vol.41 (S2), p.S71-S74

2008

Volltextzugriff (PDF)

Capture–recapture analysis to estimate the incidence of invasive meningococcal disease in Germany, 2003

Epidemiology and infection, 2007-05, Vol.135 (4), p.657-664

2007

Volltextzugriff (PDF)

Allo-SCT using BU, CY and melphalan for children with AML in second CR

Bone marrow transplantation (Basingstoke), 2013-05, Vol.48 (5), p.651-656

2013

Volltextzugriff (PDF)

Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000

Klinische Padiatrie, 2013-05, Vol.225 Suppl 1, p.S62

2013

Volltextzugriff (PDF)

Dendritic cell deficiencies in pediatric acute lymphoblastic leukemia patients

Leukemia, 2006-04, Vol.20 (4), p.645-649

2006

Volltextzugriff (PDF)

Childhood secondary ALL after ALL treatment

Leukemia, 2007-07, Vol.21 (7), p.1431-1435

2007

Volltextzugriff (PDF)

In Childhood Acute Lymphoblastic Leukemia, Blasts at Different Stages of Immunophenotypic Maturation Have Stem Cell Properties

Cancer cell, 2008-07, Vol.14 (1), p.47-58

2008

Volltextzugriff (PDF)

Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers

Journal of cancer research and clinical oncology, 2023-03, Vol.149 (3), p.1195-1209

2023

Volltextzugriff (PDF)

Allogeneic haematopoietic stem cell transplantation in children with acute lymphoblastic leukaemia: the BFM IBFM EBMT concepts

Bone marrow transplantation (Basingstoke), 2005-03, Vol.35 (S1), p.S9-S11

2005

Volltextzugriff (PDF)

Pharmacokinetic monitoring of intravenous cyclosporine A in pediatric stem-cell transplant recipients. The trough level is not enough

Pediatric transplantation, 2009-06, Vol.13 (4), p.444-450

2009

Volltextzugriff (PDF)

1 – 25 von 305

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(278)
Mit Volltextzugriff
(293)

Publikationsform

Sprache

Englisch
(275)
Deutsch
(40)
Japanisch
(32)

Erscheinungsjahr

n.n

Thema

Science & Technology
(162)
Life Sciences & Biomedicine
(153)
Humans
(140)
Female
(103)
Male
(69)
Oncology
(68)
Biological And Medical Sciences
(66)
Medical Sciences
(64)
Child
(62)
Hematology
(57)
Child, Preschool
(50)
Middle Aged
(49)
Adolescent
(47)
Hematologic And Hematopoietic Diseases
(39)
Breast Cancer
(38)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(37)
Adult
(36)
Infant
(35)
Aged
(34)
Risk Factors
(34)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000

IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol

Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008

Time point-dependent concordance of flow cytometry and real-time quantitative polymerase chain reaction for minimal residual disease detection in childhood acute lymphoblastic leukemia

Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia

Analysis of minimal residual disease by Ig TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data

Bloodstream infection in paediatric cancer centres—leukaemia and relapsed malignancies are independent risk factors

Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting

Risk assessment of relapse by lineage-specific monitoring of chimerism in children undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia

The Fc-engineered CD19 antibody MOR208 (XmAb5574) induces natural killer cell-mediated lysis of acute lymphoblastic leukemia cells from pediatric and adult patients

Dental status does not predict infection during stem cell transplantation: a single-center survey

Therapy of steroid-refractory acute GVHD with CD52 antibody alemtuzumab is effective

Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol

Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement

Very early early relapses of acute lymphoblastic leukemia show unexpected changes of clonal markers and high heterogeneity in response to initial and relapse treatment

Allogeneic hematopoietic SCT in children with ALL: current concepts of ongoing prospective SCT trials

Capture–recapture analysis to estimate the incidence of invasive meningococcal disease in Germany, 2003

Allo-SCT using BU, CY and melphalan for children with AML in second CR

Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000

Dendritic cell deficiencies in pediatric acute lymphoblastic leukemia patients

Childhood secondary ALL after ALL treatment

In Childhood Acute Lymphoblastic Leukemia, Blasts at Different Stages of Immunophenotypic Maturation Have Stem Cell Properties

Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers

Allogeneic haematopoietic stem cell transplantation in children with acute lymphoblastic leukaemia: the BFM IBFM EBMT concepts

Pharmacokinetic monitoring of intravenous cyclosporine A in pediatric stem-cell transplant recipients. The trough level is not enough

Suchergebnisse filtern